Platelets as modifiers of clinical phenotype in hemophilia

TheScientificWorldJournal

Volumn 6, Issue , 2006, Pages 661-668

  Yee, Donald L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Hemophilia; Phenotype; Platelets; Procoagulant; Thrombin generation

Indexed keywords

ADRENALIN;

BLEEDING; BLOOD CLOTTING; DISEASE SEVERITY; HEMOPHILIA A; HEMOSTASIS; HUMAN; PHENOTYPIC VARIATION; PLASMA FACTOR; SHORT SURVEY; THROMBIN TIME; THROMBOCYTE FUNCTION;

ANIMALS; BLOOD PLATELETS; HEMOPHILIA A; HEMOSTASIS; HUMANS; PHENOTYPE; THROMBIN;

EID: 33746152007     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2006.133     Document Type: Short Survey

References (70)

1. Kaufman, R.J., Antonarakis, S.E., and Fay, P.J. (2001) Factor VIII and hemophilia A. In Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Colman, R.W., Hirsh, J., Marder, V.J., Clowes, A.W., and George, J.N., Eds. Lippincott, Williams and Wilkins, Philadelphia. pp. 135-156.
2. Arun, B. and Kessler, C.M. (2001) Clinical manifestations and therapy of the hemophilias. In Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Colman, R.W., Hirsh, J., Marder, V.J., Clowes, A.W., and George, J.N., Eds. Lippincott, Williams and Wilkins, Philadelphia. pp. 815-824.
3. Arbini, A.A., Mannucci, P.M., and Bauer, K.A. (1995) Low prevalence of the factor V Leiden mutation among "severe" hemophiliacs with a "milder" bleeding diathesis. Thromb. Haemost. 74, 1255-1258.
4. Report on the Universal Data Collection Program. Volume 4, Number 2. 2002. Centers for Disease Control and Prevention.
5. Janco, R.L., Maclean, W.E., Perrin, J.M., and Gortmaker, S.L. (1996) A prospective study of patterns of bleeding in boys with haemophilia. Haemophilia 202-206.
6. Aznar, J.A., Magallón, M., Querol, F., Gorina, E., and Tusell, J.M. (2000) The orthopaedic status of severe haemophiliacs in Spain. Haemophilia 6, 170-176.
7. Tusell, J.M., Aznar, J.A., Querol, F., et al. (2002) Results of an orthopaedic survey in young patients with severe haemophilia in Spain. Haemophilia 8(Suppl 2), 38-42.
8. Lee, D.H., Walker, I.R., Teitel, J., et al. (2000) Effect of the factor V Leiden mutation on the clinical expression of severe hemophilia A. Thromb. Haemost. 83, 387-391.
9. Nichols, W.C., Amano, K., Cacheris, P.M., et al. (1996) Moderation of hemophilia A phenotype by the factor V R506Q mutation. Blood 88, 1183-1187.
10. Nowak-Gottl, U., Escuriola, C., Kurnik, K., et al. (2003) Haemophilia and thrombophilia. What do we learn about combined inheritance of both genetic variations? Hamostaseologie 23, 36-40.
11. Escuriola, E.C., Halimeh, S., Kurnik, K., et al. (2001) Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors. Thromb. Haemost. 85, 218-220.
12. Tizzano, E.F., Cornet, M., Domenech, M., and Baiget, M. (2002) Modifier genes in haemophilia: their expansion in the human genome. Haemophilia 8, 250-254.
13. Tizzano, E.F., Soria, J.M., Coll, I., et al. (2002) The prothrombin 20210A allele influences clinical manifestations of hemophilia A in patients with intron 22 inversion and without inhibitors. Haematologica 87, 279-285.
14. Ghosh, K., Shetty, S., and Mohanty, D. (2002) Genomic interaction in haemophilia: uncharted territory. Haemophilia 8, 157-158.
15. Ahmed, R., Kannan, M., Choudhry, V.P., and Saxena, R. (2003) Does the MTHFR 677T allele alter the clinical phenotype in severe haemophilia A? Thromb. Res. 109, 71-72.
16. van Dijk, K., van der Bom, J.G., Fischer, K., Grobbee, D.E., and van den Berg, H.M. (2004) Do prothrombotic factors influence clinical phenotype of severe haemophilia? A review of the literature. Thromb. Haemost. 92, 305-310.
17. Parise, L.V., Smyth, S.S., and Coller, B.S. (2001) Platelet morphology, biochemistry and function. In Williams Hematology. Beutler, E., Lichtman, M.A., Coller, B.S., Kipps, T.J., and Seligsohn, U., Eds. McGraw-Hill Medical Publishing Division, New York. pp. 1357-1408.
18. Clemetson, K.J. (1999) Primary haemostasis: sticky fingers cement the relationship. Curr. Biol. 9, R110-R112.
19. Cannon, C.P. and Tracy, R. (1995) Clotting for the clinician: an overview of thrombosis and antithrombotic therapy. J. Thromb. Thrombolysis 2, 95-106.
20. Colman, R.W., Clowes, A.W., George, J.N., Hirsh, J., and Marder, V.J. (2001) Overview of hemostasis. In Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Colman, R.W., Hirsh, J., Marder, V.J., Clowes, A.W., and George, J.N., Eds. Lippincott, Williams and Wilkins, Philadelphia. pp. 3-16.
21. Tracy, P.B. (2001) Role of platelets and leukocytes in coagulation. In Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Colman, R.W., Hirsh, J., Marder, V.J., Clowes, A.W., and George, J.N., Eds. Lippincott, Williams and Wilkins, Philadelphia. pp. 575-596.
22. Rawala-Sheikh, R., Ahmad, S.S., Ashby, B., and Walsh, P.N. (1990) Kinetics of coagulation factor X activation by platelet-bound factor IXa. Biochemistry 29, 2606-2611.
23. Miletich, J.P., Jackson, C.M., and Majerus, P.W. (1978) Properties of the factor Xa binding site on human platelets. J. Biol. Chem. 253, 6908-6916.
24. Nesheim, M.E., Taswell, J.B., and Mann, K.G. (1979) The contribution of bovine Factor V and Factor Va to the activity of prothrombinase. J. Biol. Chem. 254, 10952-10962.
25. Rosing, J., van Rijn, J.L., Bevers, E.M., et al. (1985) The role of activated human platelets in prothrombin and factor X activation. Blood 65, 319-332.
26. Nesheim, M.E., Furmaniak-Kazmierczak, E., Henin, C., and Cote, G. (1993) On the existence of platelet receptors for factor V(a) and factor VIII(a). Thromb. Haemost. 70, 80-86.
27. Nesheim, M.E., Pittman, D.D., Wang, J.H., et al. (1988) The binding of 35S-labeled recombinant factor VIII to activated and unactivated human platelets. J. Biol. Chem. 263, 16467-16470.
28. Ahmad, S.S., Scandura, J.M., and Walsh, P.N. (2000) Structural and functional characterization of platelet receptor-mediated factor VIII binding. J. Biol. Chem. 275, 13071-13081.
29. Sims, P.J., Wiedmer, T., Esmon, C.T., Weiss, H.J., and Shattil, S.J. (1989) Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J. Biol. Chem. 264, 17049-17057.
30. Walsh, P.N. (2004) Platelet coagulation-protein interactions. Semin. Thromb. Hemost. 30, 461-471.
31. Monroe, D.M., Hoffman, M., and Roberts, H.R. (2002) Platelets and thrombin generation. Arterioscler. Thromb. Vasc. Biol. 22, 1381-1389.
32. Sumner, W.T., Monroe, D.M., and Hoffman, M. (1996) Variability in platelet procoagulant activity in healthy volunteers. Thromb. Res. 81, 533-543.
33. Bouchard, B.A., Catcher, C.S., Thrash, B.R., Adida, C., and Tracy, P.B. (1997) Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation. J. Biol. Chem. 272, 9244-9251.
34. Keularts, I.M., Beguin, S., de Zwaan, C., and Hemker, H.C. (1998) Treatment with a GPIIb/IIIa antagonist inhibits thrombin generation in platelet rich plasma from patients. Thromb. Haemost. 80, 370-371.
35. Herault, J.P., Peyrou, V., Savi, P., Bernat, A., and Herbert, J.M. (1998) Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo. Thromb. Haemost. 79, 383-388.
36. Wegert, W., Graff, J., Kaiser, D., et al. (2002) Effects of antiplatelet agents on platelet-induced thrombin generation. Int. J. Clin. Pharmacol. Ther. 40, 135-141.
37. Siegemund, T., Petros, S., Siegemund, A., Scholz, U., and Engelmann, L. (2003) Thrombin generation in severe haemophilia A and B: the endogenous thrombin potential in platelet-rich plasma. Thromb. Haemost. 90, 781-786.
38. Beltran-Miranda, C.P., Khan, A., Jaloma-Cruz, A.R., and Laffan, M.A. (2005) Thrombin generation and phenotypic correlation in haemophilia A. Haemophilia 11, 326-334.
39. Dargaud, Y., Beguin, S., Lienhart, A., et al. (2005) Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B. Thromb. Haemost. 93, 475-480.
40. Sorensen, B. and Ingerslev, J. (2004) Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. J. Thromb. Haemost. 2, 102-110.
41. Ingerslev, J., Poulsen, L.H., and Sorensen, B. (2003) Potential role of the dynamic properties of whole blood coagulation in assessment of dosage requirements in haemophilia. Haemophilia 9, 348-352.
42. Sorensen, B. and Ingerslev, J. (2005) Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography. Haemophilia 11(Suppl 1), 1-6.
43. Sorensen, B. and Ingerslev, J. (2004) Thromboelastography and recombinant factor VIIa-hemophilia and beyond. Semin. Hematol. 41, 140-144.
44. Kunicki, T.J., Orchekowski, R., Annis, D., and Honda, Y. (1993) Variability of integrin alpha 2 beta 1 activity on human platelets. Blood 82, 2693-2703.
45. Lasne, D., Krenn, M., Pingault, V., et al. (1997) Interdonor variability of platelet response to thrombin receptor activation: influence of PlA2 polymorphism. Br. J. Haematol. 99, 801-807.
46. Furihata, K., Clemetson, K.J., Deguchi, H., and Kunicki, T.J. (2001) Variation in human platelet glycoprotein VI content modulates glycoprotein VI-specific prothrombinase sctivity. Arterioscler. Thromb. Vasc. Biol. 21, 1857-1863.
47. Yee, D.L., Sun, C.W., Bergeron, A.L., Dong, J.F., and Bray, P.F. (2005) Aggregometry detects platelet hyperreactivity in healthy individuals. Blood 106, 2723-2729.
48. Trip, M.D., Cats, V.M., van Capelle, F.J., and Vreeken, J. (1990) Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N. Engl. J. Med. 322, 1549-1554.
49. Kabbani, S.S., Watkins, M.W., Ashikaga, T., et al. (2001) Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous coronary intervention. Circulation 104, 181-186.
50. Kabbani, S.S., Watkins, M.W., Ashikaga, T., et al. (2003) Usefulness of platelet reactivity before percutaneous coronary intervention in determining cardiac risk one year later. Am. J. Cardiol. 91, 876-878.
51. Fateh-Moghadam, S., Bocksch, W., Ruf, A., et al. (2000) Changes in surface expression of platelet membrane glycoproteins and progression of heart transplant vasculopathy. Circulation 102, 890-897.
52. Tschoepe, D., Schultheiss, H.P., Kolarov, P., et al. (1993) Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation 88, 37-42.
53. Thaulow, E., Erikssen, J., Sandvik, L., Stormorken, H., and Cohn, P.F. (1991) Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 84, 613-617.
54. Lanza, G.A., Sestito, A., Iacovella, S., et al. (2003) Relation between platelet response to exercise and coronary angiographic findings in patients with effort angina. Circulation 107, 1378-1382.
55. Frossard, M., Fuchs, I., Leitner, J.M., et al. (2004) Platelet function predicts myocardial damage in patients with acute myocardial infarction. Circulation 110, 1392-1397.
56. Di Paola, J., Federici, A.B., Mannucci, P.M., et al. (1999) Low platelet alpha 2beta 1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system. Blood 93, 3578-3582.
57. Pereira, J., Quiroga, T., Pereira, M.E., et al. (2003) Platelet membrane glycoprotein polymorphisms do not influence the clinical expressivity of von Willebrand disease type 1. Thromb. Haemost. 90, 1135-1140.
58. Kunicki, T.J., Federici, A.B., Salomon, D.R., et al. (2004) An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees. Blood 104, 2359-2367.
59. Ghosh, K., Kulkarni, B., Nair, S., Shetty, S., and Mohanty, D. (2002) Human platelet alloantigen polymorphism in Glanzmann's thrombasthenia and its impact on the severity of the disease. Br. J. Haematol. 119, 348-353.
60. Welsby, I.J., Podgoreanu, M.V., Phillips-Bute, B., et al. (2005) Genetic factors contribute to bleeding after cardiac surgery. J. Thromb. Haemost. 3, 1206-1212.
61. Smith, P.S., Baglini, R., and Meissner, G.F. (1985) The prolonged bleeding time in hemophilia A: comparison of two measuring technics and clinical associations. Am. J. Clin. Pathol. 83, 211-215.
62. Walsh, P.N., Rainsford, S.G., and Biggs, R. (1973) Platelet coagulant activities and clinical severity in haemophilia. Thromb. Diath. Haemorrh. 29, 722-729.
63. London, F. and Walsh, P.N. (1996) The role of electrostatic interactions in the assembly of the factor X activating complex on both activated platelets and negatively-charged phospholipid vesicles. Biochemistry 35, 12146-12154.
64. Polgar, J., Matuskova, J., and Wagner, D.D. (2005) The P-selectin, tissue factor, coagulation triad. J. Thromb. Haemost. 3, 1590-1596.
65. Mackman, N. (2006) Role of tissue factor in hemostasis and thrombosis. Blood Cells Mol. Dis. 36(2), 104-107.
66. Hrachovinova, I., Cambien, B., Hafezi-Moghadam, A., et al. (2003) Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat. Med. 9, 1020-1025.
67. Jy, W., Horstman, L.L., Arce, M., and Ahn, Y.S. (1992) Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J. Lab. Clin. Med. 119, 334-345.
68. Berckmans, R.J., Neiuwland, R., Boing, A.N., et al. (2001) Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb. Haemost. 85, 639-646.
69. Proulle, V., Hugel, B., Guillet, B., et al. (2005) Circulating microparticles are elevated in haemophiliacs and non-haemophilic individuals aged <18 years. Br. J. Haematol. 131, 487-489.
70. World Federation of Hemophilia website. URL: http://www.wfh.org/index. asp?lang=EN. Accessed April 10, 2006.